Psych 2022

September 17-20, 2022
New Orleans, LA

Psych Congress 2022
Explore more Sleep congress materials
Material Type

Results(7)

Neuroscience
Efficacy and Safety in People Transitioning to Lower-Sodium Oxybate: Data From the Transition Experience of Patients With Narcolepsy Taking Oxybate in the Real-World (TENOR) Study
Author(s): Eileen B. Leary, PhD, RPSGT, Phyllis Zee, MD, PhD, Douglas S. Fuller, MS et al.
Hypertension Onset Among Narcolepsy Patients Newly Treated With Sodium Oxybate
Author(s): Rami H. Ben-Joseph, PhD, Virend K. Somers, MD, PhD, Jed Black, MD et al.
Dosing and Reasons for Transitioning From Sodium Oxybate to Lower-Sodium Oxybate: Data From the Transition Experience of Patients With Narcolepsy Taking Oxybate in the Real-World (TENOR) Study
Author(s): Aatif M. Husain, MD, Eileen B. Leary, PhD, RPSGT, Douglas S. Fuller, MS et al.
Efficacy of Lower-Sodium Oxybate in the Treatment of Idiopathic Hypersomnia: Evaluation of Response Based on the Idiopathic Hypersomnia Severity Scale Score
Author(s): Yves Dauvilliers, MD, PhD, Abby Chen, MS, Teresa L. Steininger, PhD et al.
Effectiveness and Optimization of Lower-Sodium Oxybate in Participants With Narcolepsy Switching From Sodium Oxybate: Interim Data From the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study
Author(s): Eileen B. Leary, PhD, RPSGT, M. Todd Kirby, PhD, Roman Skowronski, MD, PhD et al.
Efficacy of Lower-Sodium Oxybate in the Treatment of Idiopathic Hypersomnia: Evaluation of Response Based on the Epworth Sleepiness Scale Score
Author(s): Russell Rosenberg, PhD, Abby Chen, MS, Teresa L. Steininger, PhD et al.
Efficacy of Lower-Sodium Oxybate in Participants With Idiopathic Hypersomnia: Results From the Open-label Treatment Phase of a Clinical Study
Author(s): Nancy Foldvary-Schaefer, DO, MS, Michael J. Thorpy, MD, Abby Chen, MS et al.